AvantBio Corporation develops bioscience, biomedicine, and chemistry products and processes for therapeutic, bioresearch, and chemical reagent markets. The firm is developing new chemically defined animal-free supplements and basal media formulations for primary human epithelial and corneal cells used in wound healing, corneal transplant, and cosmetic applications. AvantFluor is commercializing novel sulfur fluorine intermediates based on its novel patent pending chemical processes.